Incidence of Incomplete Postoperative Neuromuscular Recovery From Anesthesia (P07535)(Completed) (INSPIRE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01181349 |
Recruitment Status :
Completed
First Posted : August 13, 2010
Results First Posted : April 2, 2012
Last Update Posted : October 14, 2015
|
Sponsor:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Brief Summary:
This is a multicenter, observational study in adult participants undergoing different types of elective surgical procedures requiring general anesthesia. During the first study period, there will be a cross-sectional evaluation of neuromuscular blockade level upon participant arrival at Post Anesthesia Care Units (PACUs). During the second study period, hospital discharge data from the participants will be collected. The purpose of this study is to determine the incidence of incomplete postoperative neuromuscular recovery from anesthesia at PACUs in Portuguese hospitals. This is a cross-sectional and retrospective study.
Condition or disease | Intervention/treatment |
---|---|
Neuromuscular Blockade | Other: Neuromuscular Blocking Agent (NMBA) |
Study Type : | Observational |
Actual Enrollment : | 350 participants |
Observational Model: | Cohort |
Official Title: | Incidence of Postoperative Residual Neuromuscular Blockade - A Multicenter, Observational Study in Portugal |
Study Start Date : | July 2010 |
Actual Primary Completion Date : | November 2010 |
Actual Study Completion Date : | November 2010 |
Group/Cohort | Intervention/treatment |
---|---|
P07535 study participants with a TOF ratio <0.9
Participants enrolled in the P07535 study who are included in the primary outcome measurement, which is defined as the incidence of postoperative residual neuromuscular blockade, who had a TOF ratio <0.9 at PACU arrival.
|
Other: Neuromuscular Blocking Agent (NMBA)
While neuromuscular blockade drug(s) are involved in this study prior to actual study initiation (this is an observational study), it should be noted that the identity, combination(s), and dosages of these drugs (also referred to as general anesthesia drug[s]) are not specified in the protocol. |
P07535 study participants with a TOF ratio ≥0.9
Participants enrolled in the P07535 study who are included in the primary outcome measurement, which is defined as the incidence of postoperative residual neuromuscular blockade, who had a TOF ratio ≥0.9 at PACU arrival.
|
Other: Neuromuscular Blocking Agent (NMBA)
While neuromuscular blockade drug(s) are involved in this study prior to actual study initiation (this is an observational study), it should be noted that the identity, combination(s), and dosages of these drugs (also referred to as general anesthesia drug[s]) are not specified in the protocol. |
Primary Outcome Measures :
- Number of Participants With Train-of-four (TOF) Ratio <0.9 at PACU Arrival [ Time Frame: Upon arrival in the PACU ]The incidence of incomplete postoperative neuromuscular recovery from general anesthesia was assessed in study participants upon arrival in the PACU, after their respective surgical procedures were completed. Neuromuscular functioning was assessed by applying repetitive TOF electrical stimulations to the ulnar nerve every 15 seconds and assessing twitch response at the adductor pollicis muscle. The TOF ratio is the ratio of the magnitude of the fourth twitch to that of the first twitch, and a ratio <0.9 indicates residual neuromuscular blockade (incomplete neuromuscular recovery).
Secondary Outcome Measures :
- Number of Participants With and Without Postoperative Residual Neuromuscular Blockade Who Received Identified Neuromuscular Blocking Agents [ Time Frame: From start of surgery through PACU arrival ]Neuromuscular blocking agents administered to participants undergoing surgical procedures were recorded. The number of participants who received atracurium, cisatracurium, rocuronium or vecuronium is presented, for participants with and without residual neuromuscular blockade.
- Number of Participants With and Without Postoperative Residual Neuromuscular Blockade Who Received Propofol or Sevoflurane [ Time Frame: From start of surgery through PACU arrival ]Anesthetic agents administered to participants undergoing surgical procedures were recorded. The number of participants who received propofol or sevoflurane is presented, for participants with and without residual neuromuscular blockade.
- Number of Participants With and Without Postoperative Residual Neuromuscular Blockade Who Received Neuromuscular Blockade Reversal Agents [ Time Frame: From end of surgery through PACU arrival, an expected average of 10 minutes ]Neuromuscular blockade reversal agents administered to participants undergoing surgical procedures were recorded. The number of participants who received such an agent is presented, for participants with and without residual neuromuscular blockade.
- Number of Participants With and Without Postoperative Residual Neuromuscular Blockade With Postoperative Events [ Time Frame: From end of surgery through hospital discharge, an expected average of 6 days ]
Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Study Population
Adult Portuguese participants undergoing different types of elective surgical procedures requiring general anesthesia with neuromuscular blocking agents
Criteria
Inclusion Criteria:
- 18 years of age or older
- Informed consent signed
- Admission for elective surgery
- Administration of nondepolarizing NMBAs during surgery
Exclusion Criteria:
- Admission for emergency surgery
- Reoperation on the same hospital admission
No Contacts or Locations Provided
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Merck Sharp & Dohme Corp. |
ClinicalTrials.gov Identifier: | NCT01181349 |
Other Study ID Numbers: |
P07535 |
First Posted: | August 13, 2010 Key Record Dates |
Results First Posted: | April 2, 2012 |
Last Update Posted: | October 14, 2015 |
Last Verified: | October 2015 |
Keywords provided by Merck Sharp & Dohme Corp.:
neuromuscular blockade; general anesthesia |
Additional relevant MeSH terms:
Neuromuscular Blocking Agents Neuromuscular Agents Peripheral Nervous System Agents Physiological Effects of Drugs |